Cigna Group $CI Shares Acquired by apricus wealth LLC

apricus wealth LLC lifted its stake in shares of Cigna Group (NYSE:CIFree Report) by 715.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 9,505 shares of the health services provider’s stock after buying an additional 8,340 shares during the period. apricus wealth LLC’s holdings in Cigna Group were worth $2,616,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Capital Research Global Investors increased its position in shares of Cigna Group by 140.2% in the 3rd quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock valued at $916,434,000 after acquiring an additional 1,855,897 shares during the period. Ameriprise Financial Inc. lifted its position in Cigna Group by 54.5% during the 3rd quarter. Ameriprise Financial Inc. now owns 2,136,311 shares of the health services provider’s stock worth $615,781,000 after acquiring an additional 753,865 shares during the period. Arrowstreet Capital Limited Partnership grew its stake in Cigna Group by 24.4% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 2,508,740 shares of the health services provider’s stock valued at $829,339,000 after purchasing an additional 492,045 shares during the last quarter. Balyasny Asset Management L.P. grew its stake in Cigna Group by 1,057.2% during the 2nd quarter. Balyasny Asset Management L.P. now owns 404,753 shares of the health services provider’s stock valued at $133,803,000 after purchasing an additional 369,775 shares during the last quarter. Finally, Man Group plc increased its holdings in shares of Cigna Group by 215.5% in the second quarter. Man Group plc now owns 532,183 shares of the health services provider’s stock valued at $175,929,000 after purchasing an additional 363,510 shares during the period. 86.99% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Cigna Group

In related news, insider Everett Neville sold 1,719 shares of the business’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the transaction, the insider directly owned 5,670 shares in the company, valued at $1,638,119.70. The trade was a 23.26% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Nicole S. Jones sold 2,307 shares of the stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the sale, the insider directly owned 32,647 shares in the company, valued at $9,432,044.77. This trade represents a 6.60% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 0.60% of the company’s stock.

Cigna Group Stock Down 1.5%

Shares of CI opened at $257.97 on Tuesday. Cigna Group has a 52 week low of $239.51 and a 52 week high of $350.00. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $67.98 billion, a price-to-earnings ratio of 11.63, a PEG ratio of 0.91 and a beta of 0.27. The stock’s 50-day moving average price is $276.81 and its 200-day moving average price is $279.82.

Cigna Group (NYSE:CIGet Free Report) last announced its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, beating the consensus estimate of $7.88 by $0.20. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The company had revenue of $72.50 billion during the quarter, compared to analysts’ expectations of $69.53 billion. During the same period last year, the business earned $6.64 earnings per share. Cigna Group’s quarterly revenue was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, sell-side analysts predict that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th were issued a dividend of $1.56 per share. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date of this dividend was Thursday, March 5th. This represents a $6.24 annualized dividend and a dividend yield of 2.4%. Cigna Group’s payout ratio is presently 28.13%.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the company. Deutsche Bank Aktiengesellschaft raised their price objective on Cigna Group from $301.00 to $304.00 and gave the stock a “buy” rating in a research note on Tuesday, February 10th. Mizuho set a $325.00 price target on shares of Cigna Group in a report on Friday, January 9th. Jefferies Financial Group raised their price target on shares of Cigna Group from $310.00 to $333.00 and gave the stock a “buy” rating in a research report on Monday, February 9th. Barclays decreased their price objective on shares of Cigna Group from $305.00 to $303.00 and set an “overweight” rating for the company in a research note on Friday, February 6th. Finally, TD Cowen upped their price objective on shares of Cigna Group from $333.00 to $338.00 and gave the company a “buy” rating in a report on Monday, February 9th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $333.11.

Read Our Latest Stock Analysis on CI

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Featured Stories

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.